Literature DB >> 7732383

Translational suppression by trinucleotide repeat expansion at FMR1.

Y Feng1, F Zhang, L K Lokey, J L Chastain, L Lakkis, D Eberhart, S T Warren.   

Abstract

Fragile X syndrome is the result of the unstable expansion of a trinucleotide repeat in the 5'-untranslated region of the FMR1 gene. Fibroblast subclones from a mildly affected patient, each containing stable FMR1 alleles with 57 to 285 CGG repeats, were shown to exhibit normal steady-state levels of FMR1 messenger RNA. However, FMR protein was markedly diminished from transcript with more than 200 repeats. Such transcripts were associated with stalled 40S ribosomal subunits. These results suggest that a structural RNA transition beyond 200 repeats impedes the linear 40S migration along the 5'-untranslated region. This results in translational inhibition by trinucleotide repeat expansion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732383     DOI: 10.1126/science.7732383

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  124 in total

1.  Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.

Authors:  Hansen Wang; Susan S Kim; Min Zhuo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation.

Authors:  G Raca; E Y Siyanova; C T McMurray; S M Mirkin
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 3.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

4.  Destabilization of tetraplex structures of the fragile X repeat sequence (CGG)n is mediated by homolog-conserved domains in three members of the hnRNP family.

Authors:  Samer Khateb; Pnina Weisman-Shomer; Inbal Hershco; Lawrence A Loeb; Michael Fry
Journal:  Nucleic Acids Res       Date:  2004-08-09       Impact factor: 16.971

Review 5.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 6.  Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

Authors:  Kun-Yong Kim; Yong Wook Jung; Gareth J Sullivan; Leeyup Chung; In-Hyun Park
Journal:  Trends Mol Med       Date:  2012-07-06       Impact factor: 11.951

7.  Signaling defects in iPSC-derived fragile X premutation neurons.

Authors:  Jing Liu; Katarzyna A Koscielska; Zhengyu Cao; Susan Hulsizer; Natalie Grace; Gaela Mitchell; Catherine Nacey; Jackline Githinji; Jeannine McGee; Dolores Garcia-Arocena; Randi J Hagerman; Jan Nolta; Isaac N Pessah; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2012-05-28       Impact factor: 6.150

Review 8.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

9.  Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.

Authors:  Bradford Coffee; Fuping Zhang; Stephanie Ceman; Stephen T Warren; Daniel Reines
Journal:  Am J Hum Genet       Date:  2002-09-13       Impact factor: 11.025

Review 10.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.